Delivery Order SPE2DB20D1050-SPE2DB25FH83G
- Not listed
- The Defense Logistics Agency awarded a $2,093.98 delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 15, 2025. This firm fixed-price contract was competitively awarded without set-aside designations and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a $6,756.60 firm fixed price delivery order to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal spray, with an ultimate completion date of July 25, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $1,452.39 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 13, 2025. This firm fixed-price contract was competitively awarded without set-aside provisions and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $3,580.78 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is an FDA-approved nasal spray formulation of diazepam used for acute seizure management, representing a specialty...
- The Defense Logistics Agency awarded a $2,267.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of July 28, 2025. This non-competitive delivery order, issued on July 25, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be performed at the...
- The Defense Logistics Agency awarded a delivery order valued at $6,761.00 to AmerisourceBergen Drug Corp for the supply of Valtoco 10 mg nasal sprays, with an ultimate completion date of August 1, 2025. This firm fixed-price contract represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a FDA-approved nasal spray formulation of diazepam used for acute seizure management, making this procurement part of the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Valtoco 10 mg nasal sprays, with a ceiling value of $7,354.61. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by August 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,678.34 for Valtoco 15 mg nasal sprays on July 23, 2025, with an ultimate completion date of July 24, 2025. The contract utilizes firm fixed price terms and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,644.86 to AmerisourceBergen Drug Corp for the supply of Valtoco 15 mg nasal sprays. This firm fixed-price contract, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for the supply of Valtoco 10 mg nasal sprays. This firm fixed price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, was awarded without a set-aside designation through competitive procurement. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB25FH83GDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,126.10 for Valtoco 5 mg nasal sprays, with an ultimate completion date of August 13, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is an FDA-approved nasal spray formulation of diazepam used for acute seizure management in patients with seizure disorders. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. This delivery order exemplifies the company's role in fulfilling the Defense Health Agency's pharmaceutical supply requirements through the DLA's medical supply chain, supporting military readiness and healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/12/25 |